0001209191-19-060111.txt : 20191211 0001209191-19-060111.hdr.sgml : 20191211 20191211192117 ACCESSION NUMBER: 0001209191-19-060111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191209 FILED AS OF DATE: 20191211 DATE AS OF CHANGE: 20191211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JACOB LEONARD S CENTRAL INDEX KEY: 0001049713 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 191280747 MAIL ADDRESS: STREET 1: C/O INKINE PHARMACEUTICAL COMPANY INC STREET 2: 425 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-09 0 0001016169 ANTARES PHARMA, INC. ATRS 0001049713 JACOB LEONARD S C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 0 0 0 Common Stock 2019-12-09 4 M 0 80000 1.60 A 377563 D Common Stock 2019-12-09 4 S 0 80000 4.6317 D 297563 D Common Stock 2019-12-09 4 M 0 80000 1.66 A 377563 D Common Stock 2019-12-09 4 S 0 80000 4.6222 D 297563 D Common Stock 2019-12-09 4 S 0 84814 4.6317 D 212749 D Stock Option (right to buy) 1.60 2019-12-09 4 M 0 80000 0.00 D 2011-05-27 2020-05-26 Common Stock 80000 0 D Stock Option (right to buy) 1.66 2019-12-09 4 M 0 80000 0.00 D 2012-05-17 2021-05-16 Common Stock 80000 0 D The stock option exercises and sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. /s/Keith Muckenhirn as attorney-in-fact for Leonard S. Jacob 2019-12-11